(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

QFT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

QFT

ST13

US500000079045882

Class

1, 5

Filing

79045882

Registration

3654832

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

47

Latest update

06/12/2019

Trademark type

Word

Nice classes

1, 5

Filing date

09/14/2007

Registration date

07/14/2009

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/12/2019

Last transaction

06/12/2019

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

Chadstone, AU

Examiner

MEIER, SHARON A

Law office

M30

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Cellestis Limited
Cellestis Limited
Cellestis Limited

Representatives

Victoria Friedman Dennemeyer & Associates, LLC

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical and biological reagents for use in vitro diagnostic test kits for laboratory and research use; chemical and biological peptides for laboratory or research use; chemical and biological antigens for laboratory and research use; chemical and biological mitogens for laboratory and research use; in vitro diagnostic test kits to aid the detection of infection and cell mediated immune responses for scientific and research use; assays for laboratory and research use; biological tissueblood stem cellsplasmaumbilical cords and placentas for laboratory or research use

Class 5

Chemical and biological reagents for use in vitro diagnostic test kits for medical diagnostic use; chemical and biological peptides for medical diagnostic use; chemical and biological antigens for medical diagnostic use; chemical and biological mitogens for clinical or medical diagnostic use; medicalclinical and diagnostic reagents and assays for testing of body fluidsblood and plasma; whole blood; blood plasma; in vitro diagnostic test kits for use in detecting infection and cell mediated immune responses for medical and veterinary use

Publications

History of USPTO decisions and trademark events.

47 publications found

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

06/12/2019

71AG

REGISTERED-SEC.71 ACCEPTED

06/12/2019

ES71

TEAS SECTION 71 RECEIVED

06/04/2019

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

07/14/2018

RNWL

INTERNATIONAL REGISTRATION RENEWED

09/28/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/27/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/18/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/10/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/16/2016

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

08/07/2015

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

08/07/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/07/2015

ES75

TEAS SECTION 71 & 15 RECEIVED

07/07/2015

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/27/2013

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

07/29/2010

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/21/2009

FIMP

FINAL DISPOSITION PROCESSED

10/21/2009

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/14/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

07/14/2009

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/15/2009

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/30/2009

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/30/2009

PUBO

PUBLISHED FOR OPPOSITION

04/28/2009

NPUB

NOTICE OF PUBLICATION

04/08/2009

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/23/2009

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/22/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/20/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/19/2009

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/19/2009

CNRT

NON-FINAL ACTION MAILED

12/08/2008

CNRT

NON-FINAL ACTION WRITTEN

12/05/2008

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

12/03/2008

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

09/22/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/05/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/04/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/27/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/27/2008

ALIE

ASSIGNED TO LIE

06/27/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/27/2008

RFNT

REFUSAL PROCESSED BY IB

01/25/2008

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/28/2007

RFRR

REFUSAL PROCESSED BY MPU

12/28/2007

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/28/2007

CNRT

NON-FINAL ACTION WRITTEN

12/27/2007

DOCK

ASSIGNED TO EXAMINER

12/18/2007

NWAP

NEW APPLICATION ENTERED

11/30/2007

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/29/2007

Continuous trademark protection

Get notified about every new filing that threatens QFT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.